BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27538802)

  • 21. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients.
    Ahmed KA; Wilder RB
    Int Braz J Urol; 2015; 41(1):78-85. PubMed ID: 25928512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term outcome of testicular seminoma in 294 patients].
    Song Y; Yang L; Ma JH; Liu XF; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):626-9. PubMed ID: 19102945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?
    Kohut RM; Minnillo BJ; Kypriotakis G; Abouassaly R; Zhu H
    Urology; 2014 Dec; 84(6):1319-24. PubMed ID: 25432823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
    Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
    Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
    Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
    Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.
    Sesterhenn IA; Weiss RB; Mostofi FK; Stablein DM; Rowland RG; Falkson G; Rivkind SE; Vogelzang NJ
    J Clin Oncol; 1992 Jan; 10(1):69-78. PubMed ID: 1309382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The search for biomarkers of metastatic seminoma.
    Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
    Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
    Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer.
    Albqami N; Janetschek G
    J Endourol; 2005; 19(6):683-92; discussion 692. PubMed ID: 16053357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
    Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
    J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer.
    Fujimura T; Takahashi S; Urano T; Xiaoqiang L; Ogushi T; Muramatsu M; Ouchi Y; Kitamura T; Homma Y; Inoue S
    Int J Urol; 2009 Mar; 16(3):329-32. PubMed ID: 19207611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ten-year experience with testicular cancer at a tertiary care hospital in a resource-limited setting: a single centre experience in Tanzania.
    Chalya PL; Simbila S; Rambau PF
    World J Surg Oncol; 2014 Nov; 12():356. PubMed ID: 25418694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex cord tumour of the adult testis.
    Köksal IT; Usta M; Ciftcioglu A; Erdogru T; Kukul E; Baykara M
    Int Urol Nephrol; 2003; 35(3):365-7. PubMed ID: 15160540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed sex cord stromal tumor and incidental findings of perineural and intravascular extraparenchymal Leydig cells: a potential diagnostic pitfall.
    Athanazio DA; de Oliveira Cruz A; de Farias GB
    Int Urol Nephrol; 2020 Apr; 52(4):693-695. PubMed ID: 31828477
    [No Abstract]   [Full Text] [Related]  

  • 40. Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study.
    Fresneau B; Orbach D; Faure-Conter C; Verité C; Castex MP; Kalfa N; Martelli H; Patte C
    Pediatr Blood Cancer; 2015 Dec; 62(12):2114-9. PubMed ID: 26206391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.